Document Classification

Section Type: RESULTS

Text: The total effective rate of the treatment group was 80. 00 %, which surpassed the control group (71. 43 %) (P < 0. 01) ; Zhifang I could improve the image of B-mode ultrasonography and was better than Xuezhikang in ameliorating the clinical symptoms (P < 0. 05) ; Zhifang I could significantly decrease the serum uric acid (UA) (P < 0. 01), while Xuezhikang had no obvious therapeutic effect on it (P > 0. 05) ; Zhifang I was as good as Xuezhikang in recovering alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (gamma-GT), total cholesterol (TC) and triglyceride (TG) (P > 0. 05).